Arcede Pharma is a pharmaceutical company. The company conducts research and development in the area of chronic obstructive pulmonary disease, including abbreviated COPD, and severe asthma. The company's product portfolio includes a number of drugs intended for the treatment and alleviation of the above ailments. The largest operations are in the Nordic market. The company was established via a spin-off of Respiratorius in 2022 and is headquartered in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
0.3
%
13,10%
Latest
2.59
High
2.59
Low
2.05
Volume
28 885
Turnover (SEK)
65 768
Market Value (MSEK)
15,1
Time (Latest trade)

Board

CEO

  • Mia Lundblad

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 11,24 11,24 2022-12-28
Avanza Pension 6,89 6,89 2022-12-28
Valcuria Holding AB 3,86 3,86 2022-12-28
Ben Hayes 2,34 2,34 2022-12-28
Hans Harvig 1,72 1,72 2022-12-28
Shabo Investment Group AB 1,70 1,70 2022-12-28
Nordnet Pensionsförsäkring 1,30 1,30 2022-12-28
Benny Bengtsson 1,18 1,18 2022-12-28
Andreas Bylin 1,11 1,11 2022-12-28
Ted Nilsson 1,07 1,07 2022-12-28
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-02-13 Bokslutskommuniké 2023

  • 2023-05-12 Årsstämma 2023

Annual reports, prospectus etc.